World's Best Scientists 2026 revealed!
Linda M. Pilarski

Linda M. Pilarski

D-Index & Metrics

Immunology

D-Index
67
Citations
14019
World Ranking
2692
National Ranking
59

Overview

Linda M. Pilarski is affiliated with the University of Alberta in Canada. Their research spans multiple intersecting fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Agricultural and Biological Sciences. These fields reflect a broad multidisciplinary approach centered on both human health and biological systems.

The main topics of their research cover areas such as Multiple Myeloma research and treatments, RNA research and splicing, peptidase inhibition and analysis, as well as studies related to Escherichia coli. Additionally, their work touches on animal disease management and epidemiology, including related research on Salmonella and Campylobacter epidemiology.

Recent publications by Linda M. Pilarski illustrate their research focus and include:

  • Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics, 2023, published in Blood Cancer Journal
  • Comparison of a Miniaturized Cassette PCR System with a Commercially Available Platform for Detecting Escherichia coli in Beef Carcass Swabs, 2021, published in Micromachines

Their frequent co-authors include:

  • Daisuke Ogiya
  • Zuzana Chyra
  • Sigitas Verselis
  • Morgan O'Keefe
  • Jacquelyn Cobb

Their work has been published primarily in venues such as Blood Cancer Journal and Micromachines, emphasizing topics in oncology, hematology, molecular biology, and agricultural science. Subfields represented in their research portfolio cover hematology, molecular biology, oncology, endocrinology, and agronomy and crop science, highlighting the diverse nature of their scientific inquiries.

Best Publications

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

    Jonathan J. Keats;Tony Reiman;Christopher A. Maxwell;Brian J. Taylor

  • In Vitro and in Vivo Targeting of Immunoliposomal Doxorubicin to Human B-Cell Lymphoma

    Lopes de Menezes De;Pilarski Lm;Allen Tm

  • Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

    J Laubach;L. Garderet;A. Mahindra;G. Gahrton

  • Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

    H M Serra;J F Krowka;J A Ledbetter;L M Pilarski

  • A High Frequency of Circulating B Cells Share Clonotypic Ig Heavy-Chain VDJ Rearrangements With Autologous Bone Marrow Plasma Cells in Multiple Myeloma, as Measured by Single-Cell and In Situ Reverse Transcriptase-Polymerase Chain Reaction

    Agnieszka J. Szczepek;Karen Seeberger;Juanita Wizniak;Michael J. Mant

  • In Multiple Myeloma, Clonotypic B Lymphocytes Are Detectable Among CD19+ Peripheral Blood Cells Expressing CD38, CD56, and Monotypic Ig Light Chain

    P L Bergsagel;A M Smith;A Szczepek;M J Mant

  • Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

    Jonathan J. Keats;Jonathan J. Keats;Jonathan J. Keats;Christopher A. Maxwell;Christopher A. Maxwell;Christopher A. Maxwell;Brian J. Taylor;Brian J. Taylor;Brian J. Taylor;Michael J. Hendzel;Michael J. Hendzel;Michael J. Hendzel

  • A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells.

    Esther G. Cen;Colin Dalton;Youlan Li;Sophia Adamia

  • Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.

    Linda M. Pilarski;Gail Hipperson;Karen Seeberger;Eva Pruski

  • Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.

    Gitte S. Jensen;Michael J. Mant;Andrew J. Belch;James R. Berenson

  • CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

    Steven P. Treon;Linda M. Pilarski;Andrew R. Belch;Abigail Kelliher

  • A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.

    Julia Kirshner;Kyle J. Thulien;Lorri D. Martin;Carina Debes Marun

  • In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]

    PL Bergsagel;AM Smith;A Szczepek;MJ Mant

  • Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone

    Steven P. Treon;Joseph A. Mollick;Mitsuyoshi Urashima;Gerrard Teoh

  • A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.

    Linda M. Pilarski

  • Receptor for Hyaluronan-Mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic Integrity

    Christopher A. Maxwell;Jonathan J. Keats;Andrew R. Belch;Linda M. Pilarski

  • Monoclonal Circulating B Cells in Multiple Myeloma: A Continuously Differentiating, Possibly Invasive, Population as Defined By Expression Of Cd45 Isoforms and Adhesion Molecules

    Linda M. Pilarski;Gitte S. Jensen

  • Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma

    Linda M. Pilarski;Andrew R. Belch

  • Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200).

    Linda M. Pilarski;Reinhard Gillitzer;Heddy Zola;Ken Shortman;Ken Shortman

  • Fluorescence Imaging of Multiple Myeloma Cells in a Clinically Relevant SCID/NOD in Vivo Model: Biologic and Clinical Implications

    Constantine S. Mitsiades;Nicholas S. Mitsiades;Ron T. Bronson;Dharminder Chauhan

Frequent Co-Authors

Steven P. Treon
Steven P. Treon Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Jason P. Acker
Jason P. Acker University of Alberta
Ian F. C. McKenzie
Ian F. C. McKenzie University of Melbourne
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Pierfrancesco Tassone
Pierfrancesco Tassone Magna Graecia University
Frederic I. Preffer
Frederic I. Preffer Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in Immunology, pursuing related online degrees can open doors to diverse healthcare careers. Many professionals transition into nursing roles, making programs like online BSN programs for non nurses an excellent starting point. These programs offer a pathway to nursing without prior clinical experience, blending foundational skills with advanced healthcare concepts.

If you're seeking a quicker route into nursing, exploring the easiest ABSN programs to get into can be beneficial. These accelerated programs are designed for individuals with previous college credits or degrees, enabling faster completion while maintaining rigorous training standards.

For those considering entry-level clinical roles, understanding which LPN programs are easiest to get into helps navigate opportunities that balance accessibility with quality education. LPNs play a critical role in patient care and can serve as a foundation for further specialization.

Finally, advancing your career as a nurse is possible through easiest online nurse practitioner programs. These degrees provide the skill set needed for autonomous practice, integrating complex immunologic and clinical knowledge to better serve patients.

Best Scientists Citing Linda M. Pilarski

Trending Scientists